The Tau Of Alzheimer's
    By Hank Campbell | November 12th 2012 02:31 PM | 2 comments | Print | E-mail | Track Comments


    From reading the link, I suspect both camps are wrong about Alzheimer's. Part of the problem is the focus on attempting to develop a lucrative drug before understanding the roots of the disease.
    Gerhard Adam
    Investors are the new "peer-review".  After all, we saw how much effort went into understanding Alzheimer's versus developing the drug by this statement.
    But TauRx didn't publish a full set of data from the trial, causing some skepticism among researchers. (Dr. Wischik says it didn't to protect the company's commercial interests).
    Nothing like good old scientific objectivity.
    With his passionate beliefs, Dr. Wischik admits he may be just as much a zealot about tau as he accuses others of being about beta amyloid. "I may be," he says. "In the end…it's down to the phase 3 trial."
    ...and thus we have the marriage between commercial interests and religous fervor.
    Mundus vult decipi